BE

Feel Foods Ltd. to Launch Plant-Based Food Truck

Thursday, September 23, 2021 - 1:30pm

The Feel Foods truck will provide on-the-go diners finished plant based ready to eat products that combine multiple Feel Foods plant-based product lines into a delicious meal or snack.

Key Points: 
  • The Feel Foods truck will provide on-the-go diners finished plant based ready to eat products that combine multiple Feel Foods plant-based product lines into a delicious meal or snack.
  • Follow the company on social media at Instagram.com/feelfoodsco to keep up to date on when the truck will be in a location near you.
  • Our Feel Foods Truck will significantly increase the Companys local presence and give consumers a great way to combine all our product offerings into a finished, ready to eat plant-based meal, states Feel Foods CEO David Greenway.
  • The plant-based food market is expected to grow at a CAGR of 11.9% from 2020 to 2027 to reach$74.2 billionby 2027.

Hyloris Appoints Jean-Luc Vandebroek as Chief Financial Officer

Thursday, September 23, 2021 - 6:00am

Lige, Belgium 23 September 2021 Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that Jean-Luc Vandebroek will be joining the Company as its Chief Financial Officer.

Key Points: 
  • Lige, Belgium 23 September 2021 Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that Jean-Luc Vandebroek will be joining the Company as its Chief Financial Officer.
  • Jean-Luc Vandebroek is a seasoned executive who most recently served as CFO of Bone Therapeutics, a publicly traded biotech company based in Gosselies, Belgium.
  • Jean-Luc Vandebroek, Chief Financial Officer of Hyloris, commented: I am very excited to join this unique and fast-growing company and look forward to working with the team and start interacting with investors and analysts over the next coming weeks.
  • Stijn Van Rompay, Chief Executive Officer of Hyloris, added: On behalf of our staff and our Board of Directors, I am very pleased to welcome Jean-Luc as our Chief Financial Officer.

Greene Concepts Set to Launch Happy Mellow Immune Support Hemp Extract Beverage by the End of the Year to Support Consumer Health in a Market Projected to Reach $216.8 Billion by 2028

Wednesday, September 22, 2021 - 4:30pm

The hemp-infused market is expected to grow to $216.8 billion by 2028 according to the company Meticulous Research.

Key Points: 
  • The hemp-infused market is expected to grow to $216.8 billion by 2028 according to the company Meticulous Research.
  • He discussed with beverage specialists his intention to create and market a drink that could support consumers health during such critical times.
  • Lenny Greene, CEO of Greene Concepts, states, At last, the launch of Happy Mellow is upon us!
  • Mr. Greene continues, Our Happy Mellow video , that we released last year, contains the previous Happy Mellow label.

Hyloris Announces Further Extension of Maxigesic® IV Footprint

Tuesday, September 21, 2021 - 6:00am

The commercial rollouts represent the first launches of Maxigesic IV in Asia and Latin America.

Key Points: 
  • The commercial rollouts represent the first launches of Maxigesic IV in Asia and Latin America.
  • We are very pleased that Maxigesic IV is gaining further international momentum with additional regulatory approvals in key markets.
  • Maxigesic IV has been developed under the collaboration agreement signed in 2012 between Hyloris and AFT Pharmaceuticals.
  • Two products are currently commercialised with partners: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid post-operative pain treatment.

Galapagos increases share capital through subscription right exercises

Monday, September 20, 2021 - 9:01pm

Mechelen, Belgium; 20 September 2021, 22.01 CET; regulated information Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises.

Key Points: 
  • Mechelen, Belgium; 20 September 2021, 22.01 CET; regulated information Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises.
  • Galapagos issued 7,600 new ordinary shares on 20 September 2021, for a total capital increase (including issuance premium) of 151,787.50.
  • Pursuant to the subscription right exercise program of Galapagos management board, members of the management board automatically are committed to exercise a minimum number of subscription rights, subject to certain conditions.
  • In accordance with the rules of this program, one management board member exercised 5,000 subscription rights.

Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation

Monday, September 20, 2021 - 1:00pm

Demonstrating BE is a key regulatory hurdle for generic drug approvals due to the high cost of conducting clinical trials.

Key Points: 
  • Demonstrating BE is a key regulatory hurdle for generic drug approvals due to the high cost of conducting clinical trials.
  • This is the fourth grant that the FDA has awarded Certara for the development of Certaras Simcyp MechDermA model.
  • Demonstrating bioequivalence is especially complex for topical, dermatological generic treatments, said Sebastian Polak, Ph.D., Senior Scientific Advisor & Head of Mechanistic Dermal Modelling at Certara.
  • Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development.

GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Friday, September 17, 2021 - 12:15pm

Dr Walid Abi-Saab, Chief MedicalOfficerat Galapagos, said: Ulcerative colitis can have significant and profound effects on the people who suffer with the condition.

Key Points: 
  • Dr Walid Abi-Saab, Chief MedicalOfficerat Galapagos, said: Ulcerative colitis can have significant and profound effects on the people who suffer with the condition.
  • Todays decision brings us one step closer to providing a new treatment option for people living with this chronic disease.
  • The CHMP positive opinion will now be reviewed by the European Commission and a decision is expected before year end 2021.
  • This positive opinion follows the previous approval of filgotinib for the treatment of patients with moderate to severe active rheumatoid arthritis.

SFMC Marketing Enablement at its Best: DESelect Crosses €1M ARR Threshold in Less than 2 Years

Wednesday, September 15, 2021 - 5:14pm

Reaching the 1 million ARR benchmark is rare in the tech startup ecosystem.

Key Points: 
  • Reaching the 1 million ARR benchmark is rare in the tech startup ecosystem.
  • Reaching this milestone validates our vision to become the leading marketing data enabler on Salesforce AppExchange Jonathan van Driessen, co-founder and CEO of DESelect.
  • To learn more about Recorded Future clients, visit DESelect Customer Success Stories
    DESelect offers the following solutions for Salesforce Marketing Cloud:
    DESelect Connect.
  • DESelect offers intuitive drag-and-drop SFMC solutions, designed exclusively for Salesforce Marketing Cloud.

Evolving Work Practices of Remote Working Supported by Technology Drives Flexible Workspace Market, Transparency Market Research

Wednesday, September 15, 2021 - 4:30pm

The evolving corporate landscape with changing work practices supported by the availability of high-speed Internet even in remote locations is driving the flexible workspace market .

Key Points: 
  • The evolving corporate landscape with changing work practices supported by the availability of high-speed Internet even in remote locations is driving the flexible workspace market .
  • The flexible workspace market in Asia Pacific is anticipated to expand at a significant growth rate in the near future.
  • The growing trend of working remotely in large corporations valued by employees has extended into the concept of flexible workspace.
  • The entry of startups in large numbers mostly for technology and services is creating profitable avenues in the flexible workspace market.

Evolving Work Practices of Remote Working Supported by Technology Drives Flexible Workspace Market, Transparency Market Research

Wednesday, September 15, 2021 - 4:30pm

ALBANY, N.Y., Sept. 15, 2021 /PRNewswire/ -- Flexible Workspace Market – Overview

Key Points: 
  • The evolving corporate landscape with changing work practices supported by the availability of high-speed Internet even in remote locations is driving the flexible workspace market .
  • The flexible workspace market in Asia Pacific is anticipated to expand at a significant growth rate in the near future.
  • The growing trend of working remotely in large corporations valued by employees has extended into the concept of flexible workspace.
  • The entry of startups in large numbers mostly for technology and services is creating profitable avenues in the flexible workspace market.